Crohn's Disease Clinical Trials in Hershey, Pennsylvania

4 studies are recruiting for crohn's disease in Hershey, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

   The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinica…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Penn State University Milton S. Hershey Medical Center ( Site 5102), Hershey, Pennsylvania

   Locations

   499 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06430801 on ClinicalTrials.gov

2. A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

   The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for…

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Penn State Health Milton S. Hershey Medical Center/ Penn State University College of Medicine, Hershey, Pennsylvania

   Locations

   54 in total

   Run by

   Takeda

   See if you can join NCT06100289 on ClinicalTrials.gov

3. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

   Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Penn State Health Milton South Hershey Medical Center /ID# 267126, Hershey, Pennsylvania

   Locations

   255 in total

   Run by

   AbbVie

   See if you can join NCT06548542 on ClinicalTrials.gov

4. A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

   The main aim of this study is to learn about medical problems (adverse events) if vedolizumab subcutaneously (SC) is given to a child or teenager with UC or CD for a long time. Other aims are to understand if the long time use of vedolizumab SC has an impact on the time period until hospital visits…

   Stage

   Phase 3

   Ages

   2 to 17

   Site

   Penn State Health Milton South Hershey Medical Center, Hershey, Pennsylvania

   Locations

   54 in total

   Run by

   Takeda

   See if you can join NCT06405087 on ClinicalTrials.gov